Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu
HB22-1116

Plant-based Medicines

Concerning establishing a policy review panel to study plant-based medicines to support mental health.
Session:
2022 Regular Session
Subject:
Human Services
Bill Summary

The bill creates the plant-based medicine policy review panel (policy review panel). The purpose of the policy review panel is to study the use of plant-based medicines to support mental health. The policy review panel operates for one year. The policy review panel shall submit a report on its findings and policy recommendations to the house of representatives public and behavioral health and human services committee and the senate health and human services committee, or any successor committees; the governor; and the department of human services.

The bill defines "plant-based medicine" as a naturally occurring hallucinogenic plant-based compound. Forms of plant-based medicine only include psilocybin, psilocyn, dimethyltryptamine, and ibogaine.


(Note: This summary applies to this bill as introduced.)

Status

Introduced
Lost

Menu

Bill Text

Sponsors

Sponsor Type Legislators
Prime Sponsor

Rep. A. Valdez
Sen. J. Ginal

Sponsor

Rep. E. Hooton

Co-sponsor

Colorado legislature email addresses ending in @state.co.us are no longer active. Please replace @state.co.us with @coleg.gov for Colorado legislature email addresses.  Details